Alex Blyth

Founder & Chief Executive Officer • LIfT BioSciences

Alex founded LIfT BioSciences in 2016 after losing his mother to pancreatic cancer and seeing a new way to revolutionise cancer treatment. He is a serial entrepreneur, inventor, economist & biologist with 20 years’ experience in disruptive healthcare. Alex helped to bring to market multiple first-in-class biopharma drugs including T-Vec the first oncolytic vaccine, Erbitux the first cancer drug to use a genetic test to guide use and Abraxane, one of the few drugs licensed for pancreatic cancer in the last decade.   

Also speaking

George Eastwood

Board Chair, Interim Executive Director • Emily Whitehead Foundation

Paula Pulsoni

Vice President, Sales and Services • World Courier

Avencia Sanchez-Mejias

Co-Founder and Chief Executive Officer • Integra Therapeutics

Event Info


Pre-Day Events

Discover more about the Pre-Day Events taking place at Advanced Therapies Europe.

2023 Sample Attendee List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.